Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
-0.25 (-2.11%)
At close: May 17, 2024, 4:00 PM
-0.58 (-5.00%)
After-hours: May 17, 2024, 6:04 PM EDT

Y-mAbs Therapeutics Statistics

Total Valuation

YMAB has a market cap or net worth of $509.04 million. The enterprise value is $434.47 million.

Market Cap 509.04M
Enterprise Value 434.47M

Important Dates

The last earnings date was Tuesday, May 7, 2024, after market close.

Earnings Date May 7, 2024
Ex-Dividend Date n/a

Share Statistics

YMAB has 43.88 million shares outstanding. The number of shares has increased by 0.25% in one year.

Shares Outstanding 43.88M
Shares Change (YoY) +0.25%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) 12.26%
Owned by Institutions (%) 68.01%
Float 25.68M

Valuation Ratios

PE Ratio n/a
Forward PE 119.05
PS Ratio 6.02
Forward PS 4.82
PB Ratio 5.13
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.14
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.01.

Current Ratio 6.15
Quick Ratio 5.47
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 6.07

Financial Efficiency

Return on equity (ROE) is -21.40% and return on invested capital (ROIC) is -24.99%.

Return on Equity (ROE) -21.40%
Return on Assets (ROA) -16.90%
Return on Capital (ROIC) -24.99%
Revenue Per Employee $844,990
Profits Per Employee -$216,660
Employee Count 100
Asset Turnover 0.66
Inventory Turnover 1.32


In the past 12 months, YMAB has paid $721,000 in taxes.

Income Tax 721,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +21.59% in the last 52 weeks. The beta is 0.77, so YMAB's price volatility has been lower than the market average.

Beta (1Y) 0.77
52-Week Price Change +21.59%
50-Day Moving Average 14.96
200-Day Moving Average 9.60
Relative Strength Index (RSI) 30.78
Average Volume (30 Days) 371,782

Short Selling Information

The latest short interest is 2.48 million, so 5.65% of the outstanding shares have been sold short.

Short Interest 2.48M
Short Previous Month 2.33M
Short % of Shares Out 5.65%
Short % of Float 9.65%
Short Ratio (days to cover) 7.28

Income Statement

In the last 12 months, YMAB had revenue of $84.50 million and -$21.67 million in losses. Loss per share was -$0.49.

Revenue 84.50M
Gross Profit 73.02M
Operating Income -25.08M
Pretax Income -20.95M
Net Income -21.67M
EBITDA -24.37M
EBIT -25.08M
Loss Per Share -$0.49
Full Income Statement

Balance Sheet

The company has $75.75 million in cash and $1.18 million in debt, giving a net cash position of $74.57 million or $1.70 per share.

Cash & Cash Equivalents 75.75M
Total Debt 1.18M
Net Cash 74.57M
Net Cash Per Share $1.70
Equity / Book Value 99.19M
Book Value Per Share 2.26
Working Capital 90.66M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.59M
Capital Expenditures n/a
Free Cash Flow -17.59M
FCF Per Share -$0.40
Full Cash Flow Statement


Gross margin is 86.41%, with operating and profit margins of -29.68% and -25.64%.

Gross Margin 86.41%
Operating Margin -29.68%
Pretax Margin -24.79%
Profit Margin -25.64%
EBITDA Margin -28.84%
EBIT Margin -29.68%
FCF Margin -20.81%

Dividends & Yields

YMAB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.25%
Shareholder Yield -0.25%
Earnings Yield -4.26%
FCF Yield -3.45%

Analyst Forecast

The average price target for YMAB is $17.14, which is 47.76% higher than the current price. The consensus rating is "Buy".

Price Target $17.14
Price Target Difference 47.76%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 24.42%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


YMAB has an Altman Z-Score of 8.29 and a Piotroski F-Score of 4.

Altman Z-Score 8.29
Piotroski F-Score 4